Drug Trial Radar · NCT07750379
Assessing the Role of Proton Pump Inhibitors in Reducing Aspiration Incidence in Pediatric Laryngomalacia Cases
Last checked: Nov 20, 2026Latest source record: Aug 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Apr 28, 2026
Primary completion
Dec 30, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Minia UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 6, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 6 months, up to 5 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Laryngomalacia is the most common congenital laryngeal anomaly in children and is frequently associated with aspiration. This randomized controlled study aims to assess the role of proton pump inhibitor (PPI) therapy in reducing the incidence of aspiration in pediatric patients with laryngomalacia. Eligible participants will be randomly assigned to either a PPI treatment group or a control group. Clinical and swallowing assessments will be performed to compare aspiration incidence and swallowing outcomes between the two groups
Conditions
- Laryngomalacia
Interventions
PPIDrug
Proton pump inhibitor therapy administered according to the study protocol
vitamin DDietary supplement
Vitamin D supplementation administered according to the study protocol.
feeding instructionBehavioral
Standard feeding instructions provided to caregivers according to the study protocol.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of aspirationTime frame: 2months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
faculty of Medicine, Minia University
Minya, Minya Governorate, Egypt · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.